PC - pyruvate carboxylase Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 713103
PC Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001261584.1 | NP_001248513.1 | pyruvate carboxylase, mitochondrial |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
pyruvate carboxylase, mitochondrial |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(4)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0285 | Amiloride | 99.96% | Yes | |
| HY-B0285A | Amiloride hydrochloride | 99.84% | Yes | |
| HY-B0285B | Amiloride hydrochloride dihydrate | 99.88% | Yes | |
| HY-B0285R | Amiloride (Standard) | 99.82% | Unkown |
Clinical Phase
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-B0285AR | Amiloride hydrochloride (Standard) | 99.59% | Phase 4 | |
| HY-W783248 | 18:1(n10)-16:0 PC - IsoPure | / | Phase 4 | |
| HY-150364A | Farabursen sodium | Inhibitor | 93.56% | Phase 3 |
| HY-156633 | Rezatapopt | p53 Activator | 99.78% | Phase 2 |
| HY-17602 | Amcasertib | Inducer | 98.03% | Phase 2 |
| HY-10254G | Mirdametinib (GMP) | Inhibitor | / | Phase 2 |
| HY-100186 | GSK-2881078 | Modulator | 99.42% | Phase 2 |
| HY-102038 | PC786 | Inhibitor | 98.91% | Phase 2 |
| HY-18696 | AMG-337 | 99.40% | Phase 2 | |
| HY-133222 | STX140 | / | Phase 2 | |
| HY-13626 | Spisulosine | 99.5% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(537)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10071 | Y-27632 | 99.91% | Unkown | |
| HY-W040193 | DSPC | 99.95% | Unkown | |
| HY-12364 | C75 | 99.91% | Unkown | |
| HY-130462 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC | 99.96% | Unkown | |
| HY-125783 | 1-Palmitoyl-sn-glycero-3-phosphocholine | 99.92% | Unkown | |
| HY-401424 | Cremophor EL-36 | / | Unkown | |
| HY-N9410 | Lysophosphatidylcholine 18:2 | 99.12% | Unkown | |
| HY-N0615 | Notoginsenoside R1 | Inhibitor | 99.93% | Unkown |
| HY-125771 | 1-Stearoyl-sn-glycero-3-phosphocholine | 99.53% | Unkown | |
| HY-70072 | D609 | Inhibitor | 98.0% | Unkown |
| HY-113123 | LysoPC(14:0/0:0) | 99.84% | Unkown | |
| HY-W140439 | 1-Oleoyl-sn-glycero-3-phosphocholine | 99.58% | Unkown | |
| HY-153910 | AGPS-IN-1 | 99.74% | Unkown | |
| HY-P1028 | Hexa-D-arginine | 99.97% | Unkown | |
| HY-158790 | (R)-HTS-3 | Inhibitor | 99.29% | Unkown |
| HY-108361 | CCG-203971 | Inhibitor | 99.89% | Unkown |
| HY-113253A | N8-Acetylspermidine dihydrochloride | 98.0% | Unkown | |
| HY-D1025 | C-Phycocyanin | / | Unkown | |
| HY-142684 | Pyruvate Carboxylase-IN-1 | Inhibitor | 99.43% | Unkown |
| HY-142870 | ZY-444 | 99.51% | Unkown | |
| HY-101392 | Harmane | Inhibitor | 99.91% | Unkown |
| HY-W440982 | SOPC | 99.86% | Unkown | |
| HY-130709 | PROTAC CDK2/9 Degrader-1 | Degrader | 99.85% | Unkown |
| HY-113166 | Dodecanoylcarnitine | 99.75% | Unkown | |
| HY-Y1667 | 2,6-Dibromophenol | Inhibitor | 99.76% | Unkown |
| HY-N6601 | Pomolic acid | Inducer | 99.97% | Unkown |
| HY-133968 | 24-Methylenecholesterol | 99.78% | Unkown | |
| HY-115062 | MJ33 lithium salt | Inhibitor | 99.0% | Unkown |
| HY-124042 | K6PC-5 | 99.27% | Unkown | |
| HY-156041 | Lysophosphatidylethanolamines, egg | 99.0% | Unkown | |
| HY-N3544 | Caryophyllene oxide | 99.71% | Unkown | |
| HY-P1298A | Sauvagine TFA | Agonist | 99.96% | Unkown |
| HY-100014 | KDM5A-IN-1 | Inhibitor | 99.64% | Unkown |
| HY-171616 | DCEM1 | Inhibitor | 99.31% | Unkown |
| HY-150364 | Farabursen | 99.74% | Unkown | |
| HY-W329357 | 15:0 Lyso PC | 99.6% | Unkown | |
| HY-140132 | PC Biotin-PEG3-azide | 97.75% | Unkown | |
| HY-W440983 | SDPC | Activator | 98.0% | Unkown |
| HY-16160 | Cysmethynil | 99.87% | Unkown | |
| HY-126726 | KOdiA-PC | 99.00% | Unkown | |
| HY-157544 | PC5-VC-PAB-MMAE | Inhibitor | 98.91% | Unkown |
| HY-N1353 | Rhamnocitrin | Inhibitor | 99.67% | Unkown |
| HY-144012 | DPPE-PEG2000 ammonium | 95.0% | Unkown | |
| HY-146985 | Cathepsin X-IN-1 | Inhibitor | 99.62% | Unkown |
| HY-138622 | 24:0 Lyso PC | Chemical | 99.70% | Unkown |
| HY-W016174 | Diphenyl sulfide | 99.71% | Unkown | |
| HY-W704966 | 2-Stearoyl-sn-glycero-3-phosphocholine | 97.79% | Unkown | |
| HY-102067 | 3289-8625 | Inhibitor | 99.19% | Unkown |
| HY-110166 | PD 90780 | 98.83% | Unkown | |
| HY-B0927 | Hydrastine | Inhibitor | 99.57% | Unkown |
| HY-130462S | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d31 | 99.0% | Unkown | |
| HY-141636 | 1-PalMitoyl-2-arachidoyllecithin | 99.49% | Unkown | |
| HY-W414591 | L-alpha-lysophosphatidylcholine, lauroyl | 99.82% | Unkown | |
| HY-126359 | 1-Stearoyl-2-linoleoyl-sn-glycero-3-phosphocholine | 98.0% | Unkown | |
| HY-W748591 | Cannflavin A | 99.20% | Unkown | |
| HY-101947 | SMI-16a | Inhibitor | 98.0% | Unkown |
| HY-107416 | RHC 80267 | Inhibitor | 99.41% | Unkown |
| HY-117766 | Opelconazole | Inhibitor | 98.41% | Unkown |
| HY-108016 | Peruvoside | 99.32% | Unkown | |
| HY-149091 | KDM5B-IN-4 | Inhibitor | 99.68% | Unkown |
| HY-W040193S | DSPC-d70 | 99.93% | Unkown | |
| HY-P1028A | Hexa-D-arginine TFA | 99.01% | Unkown | |
| HY-138555 | PROTAC BRD4 Degrader-8 | Inhibitor | 99.45% | Unkown |
| HY-122678 | LQZ-7F | 97.44% | Unkown | |
| HY-131640 | 1,2-Didecanoyl PC | 99.71% | Unkown | |
| HY-142990 | 1-Oleoyl-2-palmitoyl-sn-glycero-3-PC | 99.80% | Unkown | |
| HY-146331 | PC190723 | Inhibitor | 98.67% | Unkown |
| HY-P1831 | Proadrenomedullin (1-20), human | 99.53% | Unkown | |
| HY-157698 | 1-1(Z)-Octadecenyl-2-arachidonoyl-sn-glycero-3-PC | 99.0% | Unkown | |
| HY-121522 | SD-70 | Inhibitor | 99.20% | Unkown |
| HY-140134 | PC Biotin-PEG3-NHS ester | 95.0% | Unkown | |
| HY-W322575 | 1,2-Diheptadecanoyl-sn-glycero-3-phosphorylcholine | 99.0% | Unkown | |
| HY-113123S1 | LysoPC(14:0/0:0)-d7 | 95.40% | Unkown | |
| HY-157423 | 16:1 (DELTA 9-Cis) PC | 99.0% | Unkown | |
| HY-W190937 | PC Azido-PEG3-NHS carbonate ester | 98.72% | Unkown | |
| HY-105118A | Zaldaride maleate | Antagonist | 99.7% | Unkown |
| HY-136704 | GLS1 Inhibitor-1 | Inhibitor | 98.59% | Unkown |
| HY-147696 | SMTIN-T140 | 99.54% | Unkown | |
| HY-153754 | Phosphatidylcholine transfer protein inhibitor-1 | 98.01% | Unkown | |
| HY-153901 | PROTAC EGFR degrader 8 | Inhibitor | 98.90% | Unkown |
| HY-165029 | 1-Palmitoyl-2-linoleoyl-sn-glycero-3-PC | 99.0% | Unkown | |
| HY-N5021 | Anhydrosafflor yellow B | 91.20% | Unkown | |
| HY-P3320 | Phytochelatin 3 | 98.05% | Unkown | |
| HY-W019833 | MSPC | ≥99.0% | Unkown | |
| HY-154830 | Lysophosphatidylcholine C19:0 | 99.0% | Unkown | |
| HY-W020809 | C18(Plasm) LPC | 99.0% | Unkown | |
| HY-132197 | CBP/p300-IN-12 | Inhibitor | 99.72% | Unkown |
| HY-150023 | BI-1622 | Inhibitor | 98.02% | Unkown |
| HY-110260 | LDN-193188 | 99.69% | Unkown | |
| HY-138756 | PC DBCO-PEG4-NHS ester | 96.85% | Unkown | |
| HY-149149 | Incadronic acid | Inhibitor | 98.03% | Unkown |
| HY-101392A | Harmane hydrochloride | Inhibitor | 99.88% | Unkown |
| HY-153725 | 17:1 Lyso PC | 98.0% | Unkown | |
| HY-157666 | 13:0 PC | 99.92% | Unkown | |
| HY-157700 | Hexadecenyl-2-hydroxy-sn-glycero-3-PC | 99.79% | Unkown | |
| HY-125783S1 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d31 | 99.94% | Unkown | |
| HY-125783S3 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9-1 | 95.0% | Unkown | |
| HY-119257 | ABT-100 | ≥98.0% | Unkown | |
| HY-125771S | 1-Stearoyl-sn-glycero-3-phosphocholine-d35 | 99% | Unkown | |
| HY-P5272 | Histatin-3 TFA | Inhibitor | 98.26% | Unkown |
| HY-122056 | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine | 99.81% | Unkown | |
| HY-131652 | 1,2-Di-O-hexadecyl-sn-glycero-3-phosphocholine | 97.0% | Unkown | |
| HY-137325A | 2-Chloro-ATP sodium | 98.41% | Unkown | |
| HY-139931S | 1-Stearoyl-2-Arachidonoyl-d8-sn-glycero-3-PC | 99.0% | Unkown | |
| HY-146879S | 26:0 Lyso PC-d4 | 95.9% | Unkown | |
| HY-165997 | 1-1(Z)-Hexadecenyl-2-Palmitoyl-sn-glycero-3-PC | 97.1% | Unkown | |
| HY-W783276 | 18:1(11-cis) PC | ≥99.0% | Unkown | |
| HY-138635 | PROTAC BRD4 Degrader linker conjugate-3 | Inhibitor | 98.54% | Unkown |
| HY-10071A | Y-27632 hydrochloride hydrate | 99.65% | Unkown | |
| HY-125172 | PolyQ aggregation inhibitor C2-8 | Inhibitor | 99.9% | Unkown |
| HY-140139 | PC Alkyne-PEG4-NHS ester | 97.88% | Unkown | |
| HY-140140 | PC Mal-NHS carbonate ester | / | Unkown | |
| HY-142988 | 1-Stearoyl-2-myristoyl-sn-glycero-3-PC | 98.0% | Unkown | |
| HY-147100 | α1A-AR Degrader 9c | Inhibitor | / | Unkown |
| HY-161627 | Anemoside A3-methyl 6-aminohexanoate | Inhibitor | 98.62% | Unkown |
| HY-162890 | EGFR-IN-122 | Inhibitor | 99.98% | Unkown |
| HY-N9410S | Lysophosphatidylcholine 18:2-d9 | 98.0% | Unkown | |
| HY-P3322 | Phytochelatin 5 | 99.62% | Unkown | |
| HY-RS11190 | PROC Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W748509 | Pipernonaline | 99.30% | Unkown | |
| HY-146895S | 14:0 Lyso PC-d27 | 99.0% | Unkown | |
| HY-14830 | SAR 97276 | Inhibitor | 98.05% | Unkown |
| HY-70083 | SPK-601 | Inhibitor | 99.60% | Unkown |
| HY-N11229 | Butyl caffeate | 98.15% | Unkown | |
| HY-W440958 | 1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine | 99.90% | Unkown | |
| HY-W753474 | 1,2-Dipalmitelaidoyl-sn-glycero-3-phosphocholine | 99% | Unkown | |
| HY-103385 | NCX4040 | Inducer | 99.82% | Unkown |
| HY-108508 | SMANT hydrochloride | Inhibitor | 99.90% | Unkown |
| HY-117517 | NG-012 | Activator | 96.1% | Unkown |
| HY-138622S1 | 24:0 Lyso PC-d4 | 95.0% | Unkown | |
| HY-140138 | PC SPDP-NHS carbonate ester | 95.0% | Unkown | |
| HY-140142 | PC Azido-PEG11-NHS carbonate ester | 90.42% | Unkown | |
| HY-143883 | MS143 | 97.8% | Unkown | |
| HY-157413 | YS-67 | Inhibitor | 99.41% | Unkown |
| HY-157622 | 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine | 99% | Unkown | |
| HY-157695 | 1-(1Z-Octadecenyl)-2-docosahexaenoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-158310 | SOS1/EGFR-IN-1 | Inhibitor | 99.54% | Unkown |
| HY-159972 | PKR1 antagonist 1 | Antagonist | / | Unkown |
| HY-163683 | EB-PSMA-617 | Inhibitor | 96.38% | Unkown |
| HY-165086 | PON-PC | 99.9% | Unkown | |
| HY-172562 | BTR2004 | Inhibitor | 99.86% | Unkown |
| HY-N11001 | Erinacine U | 99.54% | Unkown | |
| HY-N3697 | Demethoxydeacetoxypseudolaric acid B | 99.76% | Unkown | |
| HY-N4192 | Toringin | 99.62% | Unkown | |
| HY-N7972 | 19-Oxocinobufotalin | 99.57% | Unkown | |
| HY-P1793 | α-Casein (90-95) | Agonist | 99.51% | Unkown |
| HY-P1793A | α-Casein (90-95) TFA | Agonist | 99.58% | Unkown |
| HY-P5754B | TAT-NEP1-40 acetate | Inhibitor | 94.33% | Unkown |
| HY-RS05191 | G6PC1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07440 | KRT17 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W127369 | 1-O-Hexadecyl-2-O-docosahexaenoyl-sn-glycero-3-phosphorylcholine | 99.6% | Unkown | |
| HY-W127380 | Arachidonoyl thio-PC | ≥98.0% | Unkown | |
| HY-W777360 | Harman-13C2,15N | Inhibitor | 99.66% | Unkown |
| HY-13626S | Spisulosine-d3 | Inducer | 99.0% | Unkown |
| HY-138622S | 24:0 Lyso PC-13C6 | 97.5% | Unkown | |
| HY-145547 | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine | 99.07% | Unkown | |
| HY-146840S | 17:0-14:1 PC-d5 | ≥99.0% | Unkown | |
| HY-150135B | D-myo-Inositol 1,4,5-trisphosphate tripotassium | Activator | 98.00% | Unkown |
| HY-156778 | Antitumor agent-120 | 96.0% | Unkown | |
| HY-157647 | 1-Stearoyl-2-Adrenoyl-sn-glycero-3-PC | 99.9% | Unkown | |
| HY-165157 | 1-1(Z)-Hexadecenyl-2-arachidonoyl-sn-glycero-3-PC | 99.0% | Unkown | |
| HY-168373 | 1-Stearoyl-2-Eicosapentaenoyl-sn-glycero-3-PC | 99.9% | Unkown | |
| HY-W040193S3 | DSPC-d83 | 99.0% | Unkown | |
| HY-W040193S4 | DSPC-d4 | 99.0% | Unkown | |
| HY-W040221 | Butanoyl PAF | Agonist | / | Unkown |
| HY-W783283 | 18:1 (8-cis) PC | ≥99.0% | Unkown | |
| HY-158025 | Anticancer agent 198 | Inhibitor | / | Unkown |
| HY-N11605S | C16(plasm)-18:1(d9) PC | / | Unkown | |
| HY-125783S2 | 1-Palmitoyl-sn-glycero-3-phosphocholine-d49 | 99% | Unkown | |
| HY-138633 | PROTAC BRD4 Degrader linker conjugate-2 | Inhibitor | 99.75% | Unkown |
| HY-105118 | Zaldaride | Inhibitor | / | Unkown |
| HY-105703 | Iproclozide | Inhibitor | / | Unkown |
| HY-107640 | WAY-170523 | Inhibitor | / | Unkown |
| HY-11055 | KP 544 | / | Unkown | |
| HY-111396 | PC58538 | Inhibitor | / | Unkown |
| HY-112661 | PC-766B | Inhibitor | / | Unkown |
| HY-113507 | PC(O-16:0/18:2(9Z,12Z)) | Substrate | / | Unkown |
| HY-113796 | Kopsoffinol | / | Unkown | |
| HY-115959 | Anticancer agent 34 | Inhibitor | / | Unkown |
| HY-115961 | Anticancer agent 36 | Inhibitor | / | Unkown |
| HY-115974 | GRPR antagonist-1 | 99.80% | Unkown | |
| HY-118147 | ML356 | Inhibitor | / | Unkown |
| HY-120561 | PC-046 | / | Unkown | |
| HY-121195 | Apalcillin | Inhibitor | / | Unkown |
| HY-121655 | Dansyllysine | / | Unkown | |
| HY-121679 | COX-2-IN-50 | Inhibitor | / | Unkown |
| HY-122056S | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d35 | / | Unkown | |
| HY-122056S1 | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d26 | / | Unkown | |
| HY-12364B | (−)-C75 | / | Unkown | |
| HY-123711 | PC170942 | Inhibitor | / | Unkown |
| HY-123715 | Anticancer agent 255 | / | Unkown | |
| HY-124152 | 3,4-Dephostatin | Inhibitor | / | Unkown |
| HY-125010 | Dicycloplatin | Inducer | / | Unkown |
| HY-125554 | KDdiA-PC | Ligand | / | Unkown |
| HY-125744 | Palmitoyl thio-PC | / | Unkown | |
| HY-125783S | 1-Palmitoyl-sn-glycero-3-phosphocholine-d9 | / | Unkown | |
| HY-129449 | AnnH31 | Inhibitor | 99.91% | Unkown |
| HY-130462S1 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d82 | 99% | Unkown | |
| HY-130462S4 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d9 | / | Unkown | |
| HY-130462S5 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d62 | / | Unkown | |
| HY-131438 | GI-149893 | Inhibitor | / | Unkown |
| HY-133101 | 14-Norpseurotin | / | Unkown | |
| HY-133233 | Thioetheramide-PC | Inhibitor | 98% | Unkown |
| HY-133968S1 | 24-Methylenecholesterol-13C | / | Unkown | |
| HY-136271 | MJ33 | Inhibitor | / | Unkown |
| HY-136480 | Chrysamine G | / | Unkown | |
| HY-136727A | Ac-LEVD-CHO TFA | Inhibitor | / | Unkown |
| HY-137348 | 10-Pyrene-PC | / | Unkown | |
| HY-13847 | GNE-555 | Inhibitor | / | Unkown |
| HY-138637 | PROTAC BRD4 Degrader-14 | Inhibitor | / | Unkown |
| HY-139231 | 1-Palmitoyl-2-formylyl PC | / | Unkown | |
| HY-139294 | PROTAC BRD4 Degrader-15 | Inhibitor | / | Unkown |
| HY-140130 | PC Biotin-PEG3-alkyne | / | Unkown | |
| HY-140131 | Biotin-PEG4-PC-PEG4-alkyne | / | Unkown | |
| HY-140133 | PC-Biotin-PEG4-PEG3-azide | / | Unkown | |
| HY-140136 | PC DBCO-PEG3-biotin | / | Unkown | |
| HY-140141 | PC Methyltetrazine-PEG4-NHS carbonate ester | / | Unkown | |
| HY-140863 | PC-PEG11-Azide | / | Unkown | |
| HY-141863 | Lepidozin G | Inducer | / | Unkown |
| HY-142958 | NF-κB-IN-2 | / | Unkown | |
| HY-143445 | EGFR-IN-48 | Inhibitor | / | Unkown |
| HY-143882 | MS5033 | Inhibitor | / | Unkown |
| HY-144808 | Anticancer agent 40 | Inhibitor | / | Unkown |
| HY-145547S | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine-d27 | / | Unkown | |
| HY-146038 | Antitumor agent-55 | / | Unkown | |
| HY-146170 | Anticancer agent 69 | / | Unkown | |
| HY-146838S | 17:0-18:1 PC-d5 | / | Unkown | |
| HY-146839S | 17:0-16:1 PC-d5 | / | Unkown | |
| HY-146841S1 | (Rac)-Lysophosphatidylcholine C19:0-d5 | / | Unkown | |
| HY-146848S | C18(Plasm)-18:1 PC-d9 | / | Unkown | |
| HY-146849S | 17:0-22:4 PC-d5 | / | Unkown | |
| HY-146850S | (11Z,14Z,17Z)-17:0-20:3 PC-d5 | / | Unkown | |
| HY-146880S | 14:0-14:0 PC-d27 | / | Unkown | |
| HY-146891S | DPPC-d31 | / | Unkown | |
| HY-146893S | 18:0-18:0 PC-d35 | / | Unkown | |
| HY-146894S | DSPC-d35 | 99.0% | Unkown | |
| HY-146924S | DL-Dipalmitoylphosphatidylcholine-d80 | 99.0% | Unkown | |
| HY-147682 | NF-κB-IN-5 | / | Unkown | |
| HY-147734 | Calpain Inhibitor-2 | Inhibitor | / | Unkown |
| HY-147852 | B-Raf IN 7 | Inhibitor | / | Unkown |
| HY-147853 | B-Raf IN 8 | Inhibitor | / | Unkown |
| HY-147854 | B-Raf IN 9 | / | Unkown | |
| HY-149434 | PROTAC AR-NTD degrader 1 | Inducer | / | Unkown |
| HY-149632 | EGFR/HER2/DHFR-IN-2 | Inhibitor | / | Unkown |
| HY-149729 | ICMT-IN-53 | Inhibitor | / | Unkown |
| HY-149976 | Pim-1 kinase inhibitor 4 | Inhibitor | / | Unkown |
| HY-149995 | Pim-1 kinase inhibitor 5 | Inhibitor | / | Unkown |
| HY-150563 | Neuroinflammatory-IN-2 | Inhibitor | / | Unkown |
| HY-151431 | Nrf2/HO-1 activator 2 | / | Unkown | |
| HY-151940 | Mal-Pc | Activator | / | Unkown |
| HY-152922 | 1-(1(Z)-Hexadecenyl)-2-linoleoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-153051 | Antitumor agent-90 | / | Unkown | |
| HY-154861 | Anticancer agent 118 | / | Unkown | |
| HY-155049 | NMDA receptor antagonist 6 | Antagonist | / | Unkown |
| HY-155227A | ALK/EGFR-IN-2 | Inhibitor | / | Unkown |
| HY-155227B | ALK/EGFR-IN-3 | Inhibitor | / | Unkown |
| HY-155610 | VEGFR-2-IN-32 | Inhibitor | / | Unkown |
| HY-155718 | fac-[Re(CO)3(L6)(H2O)][NO3] | Inducer | / | Unkown |
| HY-155719 | fac-[Re(CO)3(L3)(H2O)][NO3] | Inducer | / | Unkown |
| HY-157125 | PI3Kα-IN-14 | / | Unkown | |
| HY-157394 | eeAChE/eqBuChE-IN-1 | Inhibitor | / | Unkown |
| HY-157437 | AChE/BChE-IN-16 | Inhibitor | / | Unkown |
| HY-157501 | PC6-VC-PAB-MMAE | / | Unkown | |
| HY-157564 | Antitumor agent-135 | Inducer | / | Unkown |
| HY-157641A | (2S)-18:1 Lyso PC | / | Unkown | |
| HY-157689 | 1,2-Dieicosenoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-157696 | 18:0 Diether PC | / | Unkown | |
| HY-157880 | N3-PC | / | Unkown | |
| HY-158328A | CA IX/VEGFR-2-IN-2 | / | Unkown | |
| HY-158373 | Anticancer agent 213 | Inducer | / | Unkown |
| HY-158710 | 1-Palmitoyl-2-pyropheophorbide a-sn-glycero-3-pc | / | Unkown | |
| HY-159149 | Antitumor agent-182 | Inducer | / | Unkown |
| HY-159893 | SMO-IN-5 | / | Unkown | |
| HY-160644 | 8PC | / | Unkown | |
| HY-161502 | DHX-SP | / | Unkown | |
| HY-161783 | HDAC6-IN-45 | / | Unkown | |
| HY-161785 | EGFR-IN-117 | Inhibitor | / | Unkown |
| HY-161859 | VEGFR-2/STAT-3-IN-1 | Inhibitor | / | Unkown |
| HY-161866 | EGFR-IN-118 | Inhibitor | / | Unkown |
| HY-162304 | MAGL-IN-14 | Inhibitor | / | Unkown |
| HY-162330 | HDAC6-IN-36 | Inhibitor | / | Unkown |
| HY-162380 | Topoisomerase II inhibitor 18 | Inhibitor | / | Unkown |
| HY-162751 | Anticancer agent 249 | / | Unkown | |
| HY-162812 | H3R antagonist 4 | Inhibitor | / | Unkown |
| HY-162885 | YSY01A | / | Unkown | |
| HY-162891 | EGFR-IN-123 | Inhibitor | / | Unkown |
| HY-162895 | NL13 | / | Unkown | |
| HY-163381 | Antiproliferative agent-48 | / | Unkown | |
| HY-163632 | EGFR-IN-112 | Inhibitor | / | Unkown |
| HY-164828 | Rezatapopt analog-1 | / | Unkown | |
| HY-165030 | 1-Stearoyl-2-15(S)-HETE-sn-glycero-3-PC | / | Unkown | |
| HY-165097 | 1-Stearoyl-2-15(S)-HpETE-sn-glycero-3-PC | / | Unkown | |
| HY-165616 | NS 1231 | / | Unkown | |
| HY-165663S | 1-Myristoyl-d7-2-Linoleoyl-sn-glycero-3-PC | / | Unkown | |
| HY-166989 | 1-undecanoyl-2-hydroxy-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-167571 | 12:0 Diether PC | / | Unkown | |
| HY-167572 | 18:0 (9,10dibromo) PC | / | Unkown | |
| HY-167573 | 16:0-10 Doxyl PC | / | Unkown | |
| HY-167574 | 16:0-18:0(11-12BR) PC | / | Unkown | |
| HY-167585S | 16:0-18:2 PC-d5 | / | Unkown | |
| HY-167587S | 17:0-20:3 PC-d5 | / | Unkown | |
| HY-167816 | 1,2-Diheneicosanoyl-sn-glycero-3-phosphocholine | Inhibitor | / | Unkown |
| HY-168068 | Res-Glu3 | / | Unkown | |
| HY-168300 | Antiangiogenic agent 7 | / | Unkown | |
| HY-168371 | 1-Palmitoyl-2-13(S)-HODE-sn-glycero-3-PC | / | Unkown | |
| HY-168372 | 1-Myristoyl-2-Linoleoyl-sn-glycero-3-PC | Ligand | / | Unkown |
| HY-169006 | Evo312 | / | Unkown | |
| HY-169058 | GSTP1-1 inhibitor 2 | Inhibitor | / | Unkown |
| HY-169078 | ML234 | Inhibitor | / | Unkown |
| HY-169098 | HSP90/LSD1-IN-1 | Inhibitor | / | Unkown |
| HY-169414 | WRN inhibitor 15 | / | Unkown | |
| HY-170221 | Chol-C10-PC | / | Unkown | |
| HY-170386 | TXY541 | Inhibitor | / | Unkown |
| HY-170466 | 16:0-12 Doxyl PC | / | Unkown | |
| HY-171884 | BI-8128 | Inhibitor | / | Unkown |
| HY-172366 | BQ0413 | 95.66% | Unkown | |
| HY-172481 | DSPE-PEG1000-TAASGVRSMH | / | Unkown | |
| HY-172482 | DSPE-PEG2000-TAASGVRSMH | / | Unkown | |
| HY-172482A | DSPE-PEG3400-TAASGVRSMH | / | Unkown | |
| HY-172483 | DSPE-PEG5000-TAASGVRSMH | / | Unkown | |
| HY-172748 | 9β-Hydroxyhexahydrocannabinol | / | Unkown | |
| HY-172872 | CDK2-IN-45 | / | Unkown | |
| HY-172886 | PI3K-IN-58 | / | Unkown | |
| HY-173007 | ALK/PI3K/AKT-IN-1 | / | Unkown | |
| HY-173039 | α-Tubulin polymerization-IN-1 | / | Unkown | |
| HY-173122 | Akt1-IN-8 | Inhibitor | / | Unkown |
| HY-173597 | ZINC43120769 | Inhibitor | / | Unkown |
| HY-174397 | EED-IN-3 | Inhibitor | / | Unkown |
| HY-175017 | Survivin-IN-2 | Inhibitor | / | Unkown |
| HY-175244 | SOS1-IN-20 | Inhibitor | / | Unkown |
| HY-175555 | Tubulin-IN-54 | / | Unkown | |
| HY-175826 | USP30-IN-20 | / | Unkown | |
| HY-175841 | Tau Protein Phosphorylation-IN-1 | Inhibitor | / | Unkown |
| HY-176284 | OXPHOS-IN-2 | / | Unkown | |
| HY-17638A | Mizagliflozin (sebacate) | Inhibitor | / | Unkown |
| HY-17654 | BIEGi-1 | Inhibitor | / | Unkown |
| HY-178045 | MYC-IN-4 | Inhibitor | / | Unkown |
| HY-178057 | EGFR-IN-176 | / | Unkown | |
| HY-178133 | Pim-1 kinase-IN-14 | / | Unkown | |
| HY-178485 | SJY26 | Inhibitor | / | Unkown |
| HY-178489 | BGC1614 | / | Unkown | |
| HY-178703S | 1,2-Diheptanoyl-SN-glycero-3-phosphocholine-d9 | / | Unkown | |
| HY-178758S | 1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine-d66 | / | Unkown | |
| HY-179018 | Topoisomerase II-IN-25 | / | Unkown | |
| HY-179050 | Androgen receptor-IN-7 | / | Unkown | |
| HY-179148 | EGFR-IN-184 | / | Unkown | |
| HY-179398 | Keap1-Nrf2-IN-29 | Inhibitor | / | Unkown |
| HY-179533 | SOD1-aggregation-IN-1 | Inhibitor | / | Unkown |
| HY-179760 | 16:0-7 Doxyl PC | / | Unkown | |
| HY-179762 | 16:0 Tempo PC | / | Unkown | |
| HY-179861 | BODIPY 505/515 11:0 Lyso PC | / | Unkown | |
| HY-180155 | Keap1/Nrf2/ARE activator 2 | / | Unkown | |
| HY-180327 | NEPP11 | / | Unkown | |
| HY-180995 | VARS1-IN-1 | Inhibitor | / | Unkown |
| HY-181830 | Atz-L5 | / | Unkown | |
| HY-181999 | PC8 | / | Unkown | |
| HY-182904 | GV-001 | / | Unkown | |
| HY-183589 | Ferroptosis-IN-26 | Inhibitor | / | Unkown |
| HY-184448 | CIB-Q22 | / | Unkown | |
| HY-19378 | MIV-150 | Inhibitor | / | Unkown |
| HY-204056 | Telomerase-IN-8 | Inhibitor | / | Unkown |
| HY-403733C | JJ-450 | Antagonist | / | Unkown |
| HY-B0021S | Doxifluridine-d2 | / | Unkown | |
| HY-B0285AS | Amiloride-15N3 hydrochloride | / | Unkown | |
| HY-B0530A | Azacyclonol hydrochloride | / | Unkown | |
| HY-D3394 | SGC5 | / | Unkown | |
| HY-N10325 | Sarbronine M | / | Unkown | |
| HY-N10384 | AChE-IN-17 | Inhibitor | / | Unkown |
| HY-N10687 | Saprorthoquinone | / | Unkown | |
| HY-N11604 | 1-(1(Z)-Hexadecenyl)-2-palmitoleoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-N11605 | PC 16:0/18:1 | / | Unkown | |
| HY-N11651 | Peganumine A | / | Unkown | |
| HY-N12004 | 19-Hydroxy-10-deacetylbaccatin III | / | Unkown | |
| HY-N12123 | Peimisine 3-O-β-D-glucopyranoside | / | Unkown | |
| HY-N12170 | Kissoone C | / | Unkown | |
| HY-N12225 | Isoasiaticoside | / | Unkown | |
| HY-N12466 | 3′-O-Demethyl-4′-N-demethyl-4′-N-acetyl-4′-epi-staurosporine | Inhibitor | / | Unkown |
| HY-N12606 | Neodidymelliosides A | Inhibitor | / | Unkown |
| HY-N12821 | visamminol-3'-O-glucoside | / | Unkown | |
| HY-N13772 | 3'-O-Methyltaxifolin | Inducer | / | Unkown |
| HY-N15711 | Ganoleucoin R | Inhibitor | / | Unkown |
| HY-N15785 | 18:0-Azo PC | / | Unkown | |
| HY-N15792 | 18:1 Aminoethyl PC | / | Unkown | |
| HY-N15810 | 18:0 Aminoethyl PC | / | Unkown | |
| HY-N15919 | a15:0-i15:0 PC | / | Unkown | |
| HY-N15920 | 16:0-17:0 Cyclo PC | / | Unkown | |
| HY-N15924 | 16:0-a15:0 PC | / | Unkown | |
| HY-N15926 | ent-POPC | / | Unkown | |
| HY-N15928 | 16:0-i15:0 PC | / | Unkown | |
| HY-N15933 | 16:0(Alkyne)-18:1 PC | / | Unkown | |
| HY-N15937 | IKS02 | / | Unkown | |
| HY-N15948 | 18:0-16:0(16-Azido) PC | / | Unkown | |
| HY-N15949 | 18:0 Carboxypentyl PC | / | Unkown | |
| HY-N15955 | 18:1 Propargyl PC | / | Unkown | |
| HY-N15957 | 18:0 Azidoethyl PC | / | Unkown | |
| HY-N15966 | 18:0 Propargyl PC | / | Unkown | |
| HY-N15984 | 18:1-12:0 Biotin PC | / | Unkown | |
| HY-N15986 | 4ME 16:0 Diether PC | / | Unkown | |
| HY-N15994 | 16:0-18:0(4,5-Dibromo) PC | / | Unkown | |
| HY-N15996 | 16:0-18:0 (9-10BR) PC | / | Unkown | |
| HY-N15997 | 14:0-14:0(COOH) PC | / | Unkown | |
| HY-N16066 | Candidusin A | / | Unkown | |
| HY-N16426 | Mycoleptone A | Inhibitor | / | Unkown |
| HY-N17611 | 5,6,7-Trihydroxy-4'-methoxyflavone | Inhibitor | / | Unkown |
| HY-N17718 | Urushiol (15:3) | Inhibitor | / | Unkown |
| HY-N17920A | 6β-Methoxygeniposide | / | Unkown | |
| HY-N18211 | 1α,3α-Dihydroxyl-7α-tigloyloxy-12α-ethoxylnimbolinin | / | Unkown | |
| HY-N3489 | Isodihydrofutoquinol B | / | Unkown | |
| HY-N3550 | Catalponol | / | Unkown | |
| HY-N3928 | Garciniaxanthone E | / | Unkown | |
| HY-N3938 | Gelsemiol | / | Unkown | |
| HY-N7535 | Chlorovaltrate K | / | Unkown | |
| HY-N8103 | Heishuixiecaoline A | / | Unkown | |
| HY-N9085 | Neuchromenin | / | Unkown | |
| HY-N9257 | 8-Hydroxypinoresinol4,4'-di-O-β-D-glucopyranoside | / | Unkown | |
| HY-P10786 | LinTT1 peptide | Inhibitor | / | Unkown |
| HY-P11082 | APGW-amide | / | Unkown | |
| HY-P11313 | Catestatin (rat) | / | Unkown | |
| HY-P1298 | Sauvagine | Agonist | / | Unkown |
| HY-P3321A | Phytochelatin 4 TFA | / | Unkown | |
| HY-P3322A | Phytochelatin 5 TFA | / | Unkown | |
| HY-P3323 | Phytochelatin 6 | / | Unkown | |
| HY-P3323A | Phytochelatin 6 TFA | / | Unkown | |
| HY-P5156 | BDS-I | Inhibitor | / | Unkown |
| HY-P5754 | TAT-NEP1-40 | Inhibitor | / | Unkown |
| HY-P5754A | TAT-NEP1-40 TFA | Inhibitor | / | Unkown |
| HY-P5876 | Proadrenomedullin (N-20) (bovine, porcine) | Antagonist | / | Unkown |
| HY-RS05192 | G6PC2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS05193 | G6PC3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10111 | PC Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10808 | PODXL Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W019821 | 23:2 Diyne PC [DC(8,9)PC] | / | Unkown | |
| HY-W019854 | 14:1 (Δ9-Trans) PC | / | Unkown | |
| HY-W040172 | 06:0 Diether PC | / | Unkown | |
| HY-W040193B | (S)-DSPC | / | Unkown | |
| HY-W040193S2 | DSPC-d79 | 99.3% | Unkown | |
| HY-W040193S5 | DSPC-d9 | 99.0% | Unkown | |
| HY-W040193S6 | DSPC-d13 | 99.0% | Unkown | |
| HY-W331017 | 1-Hexacosanoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W339358 | 11:0 PC | / | Unkown | |
| HY-W340037 | 1,2-Dibutyryl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W340113 | 15:0 PC | / | Unkown | |
| HY-W403046A | D-myo-Inositol-4-phosphate monoammonium | Activator | / | Unkown |
| HY-W414749 | 08:0 Lyso PC | / | Unkown | |
| HY-W440957 | PMPC | / | Unkown | |
| HY-W472153 | β-Glucuronidase-IN-5 | Inhibitor | / | Unkown |
| HY-W590534S | 1-Palmitoyl-sn-glycero-3-phosphocholine-d3 | / | Unkown | |
| HY-W590535 | 19:0 PC | / | Unkown | |
| HY-W700834 | Harman-d3 | / | Unkown | |
| HY-W725397 | 23:0 PC | / | Unkown | |
| HY-W725552 | 16:0-(12-PAHSA) PC | / | Unkown | |
| HY-W753387 | TopFluor-20:4 PC - IsoPure | / | Unkown | |
| HY-W783245 | 16:0-18:1(n10) PC - IsoPure | / | Unkown | |
| HY-W783247 | 18:1(n7)-16:0 PC - IsoPure | / | Unkown | |
| HY-W783249 | 20:4-16:0 PC - IsoPure | / | Unkown | |
| HY-W800732 | 1,2-Dilinoleoyl-sn-glycero-3-PC | / | Unkown | |
| HY-W800734 | 1-Myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W800785 | 16:0-23:2 Diyne PC | / | Unkown | |
| HY-W923483 | C16-18:1 PC | 99% | Unkown | |
| HY-106705 | Apalcillin sodium | Inhibitor | / | Unkown |
| HY-115731 | Tocol | / | Unkown | |
| HY-121619 | Jacaric acid | Inducer | / | Unkown |
| HY-125783R | 1-Palmitoyl-sn-glycero-3-phosphocholine (Standard) | / | Unkown | |
| HY-130462S2 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-13C16 | / | Unkown | |
| HY-130462S3 | 1-Palmitoyl-2-oleoyl-sn-glycero-3-PC-d64 | / | Unkown | |
| HY-134225 | 1-O-Hexadecyl-2-arachidonoyl-sn-glycero-3-PC | / | Unkown | |
| HY-137225 | HTS07944 | / | Unkown | |
| HY-141636S | 1-PalMitoyl-2-arachidoyllecithin-d9-1 | / | Unkown | |
| HY-143857S | 22:0 Lyso PC-13C6 | / | Unkown | |
| HY-144086S | 22:0 Lyso-PC-d4 | / | Unkown | |
| HY-146841S | Lysophosphatidylcholine C19:0-d5 | / | Unkown | |
| HY-146925S | 15:0 Lyso PC-d5 | / | Unkown | |
| HY-149715 | R1-11 | Inhibitor | / | Unkown |
| HY-157404 | Pim-1/2 kinase inhibitor 2 | Inhibitor | / | Unkown |
| HY-157423A | 16:1 (DELTA 9-Cis) PC,chloroform | / | Unkown | |
| HY-157672 | 18:1-14:0 PC | / | Unkown | |
| HY-157675 | 1,2-Dinervonoyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-159118 | PC-Qz1 | Inhibitor | / | Unkown |
| HY-164164 | 16:0-16:0(Acrylate) PC | / | Unkown | |
| HY-164283 | DOCP | / | Unkown | |
| HY-164621 | A3AR antagonist 5 | Antagonist | 98.17% | Unkown |
| HY-165430 | Antiviral agent 67 | / | Unkown | |
| HY-165785 | Phosphatidylcholine, PC (heart, bovine) | / | Unkown | |
| HY-167586S | 18:0-22:6 PC-d9 | / | Unkown | |
| HY-168757 | PSMA precursor-1 | Ligand | / | Unkown |
| HY-168796 | 1-Palmitoyl-2-13(S)-HpODE-sn-glycero-3-PC | / | Unkown | |
| HY-169476 | Pyrrolidine linoleamide | / | Unkown | |
| HY-169830 | 2-(Cyclohexylmethyl)-plumbagin | / | Unkown | |
| HY-175111 | 1-Stearoyl-2-17(S)-HDoTE-sn-glycero-3-PC | / | Unkown | |
| HY-175113 | 1-1(Z)-Octadecenyl-2-adrenoyl-sn-glycero-3-PC | / | Unkown | |
| HY-176085 | Heptanoyl thio-PC | Substrate | / | Unkown |
| HY-178040 | Insecticidal agent 26 | Inhibitor | / | Unkown |
| HY-179879 | 16:0-16 Doxyl PC | / | Unkown | |
| HY-179880 | 16:0-18:1 Tempo PC | / | Unkown | |
| HY-179883 | 16:0-5 Doxyl PC | / | Unkown | |
| HY-179896 | BODIPY TMR Lyso PC ester | / | Unkown | |
| HY-180145 | Furin-IN-3 | Inhibitor | / | Unkown |
| HY-182143 | PC Amino-modifier phosphoramidite | / | Unkown | |
| HY-182159 | PC Spacer phosphoramidite | / | Unkown | |
| HY-182188 | PC biotin phosphoramidite | / | Unkown | |
| HY-183437 | MAO-B-IN-57 | Inhibitor | / | Unkown |
| HY-186004 | G6PC modulator-1 | / | Unkown | |
| HY-B0285S | Amiloride-15N3 | / | Unkown | |
| HY-N1107 | Uzarigenin | / | Unkown | |
| HY-N12001 | 6-Epiagarotetrol | / | Unkown | |
| HY-N14417 | Indocarbazostatin | / | Unkown | |
| HY-N14424 | Indocarbazostatin B | / | Unkown | |
| HY-N16079 | C18(Plasm)-18:1 PC | / | Unkown | |
| HY-N16165 | 1,2-Dilinolenoyl-sn-Glycero-3-Phosphatidylcholine | / | Unkown | |
| HY-N17795 | 26-Hydroxyl-20(S)-protopanaxadiol | / | Unkown | |
| HY-N18868 | 1-Palmitoyl-2-capryloyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-N3562 | Cedrin | Inhibitor | / | Unkown |
| HY-N3563 | Celaphanol A | / | Unkown | |
| HY-N9861 | Kayaflavone | Inhibitor | / | Unkown |
| HY-RS16637 | pc Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17167 | Proc Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18605 | Cbx2 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19229 | Podxl Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20932 | G6pc3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23072 | Pc Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25718 | Podxl Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27449 | G6pc3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W040193GL | DSPC (GMP Like) | / | Unkown | |
| HY-W040193S1 | DSPC-d74 | 99% | Unkown | |
| HY-W1121746 | PC Linker phosphoramidite | / | Unkown | |
| HY-W292927 | (E)-Antiviral agent 67 | Inhibitor | / | Unkown |
| HY-W437569 | Melicopine | Inhibitor | / | Unkown |
| HY-W440982A | (Rac)-SOPC | / | Unkown | |
| HY-W588314 | 2-16:0 Lyso PC | / | Unkown | |
| HY-W713925 | Diheptanoyl Thio-PC | / | Unkown | |
| HY-W725327 | 1,2-Dipropionyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W725352 | 16:0 2-PC | / | Unkown | |
| HY-W725399 | 1,2-Dilignoceroyl-sn-glycero-3-phosphocholine | / | Unkown | |
| HY-W753557 | Avocadene | Inhibitor | / | Unkown |
| HY-W778562 | 10-Deacetyl-13-oxobaccatin III | / | Unkown | |
| HY-W783246 | 16:0-18:1(n7) PC - IsoPure | / | Unkown | |
| HY-W839203 | 22:0 PC | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P990281 | Anti-Mouse CD25/IL-2Rα Antibody (PC-61.5.3) | 99% | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service